These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37614534)

  • 21. Prevalence and characterization of somatic mutations in Chinese aldosterone-producing adenoma patients.
    Wang B; Li X; Zhang X; Ma X; Chen L; Zhang Y; Lyu X; Tang Y; Huang Q; Gao Y; Fan Y; Ouyang J
    Medicine (Baltimore); 2015 Apr; 94(16):e708. PubMed ID: 25906099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetics of Aldosterone-Producing Adenoma in Korean Patients.
    Hong AR; Kim JH; Song YS; Lee KE; Seo SH; Seong MW; Shin CS; Kim SW; Kim SY
    PLoS One; 2016; 11(1):e0147590. PubMed ID: 26807823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploration of KCNJ5 Somatic Mutation and CYP11B1/CYP11B2 Staining in Multiple Nodules in Primary Aldosteronism.
    Xie J; Zhang C; Wang X; Jiang Y; Wu L; Ye L; Wang X; Xie W; Xu H; Wang W
    Front Med (Lausanne); 2022; 9():823065. PubMed ID: 35492351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary aldosteronism diagnostics:
    Rege J; Turcu AF; Rainey WE
    Gland Surg; 2020 Feb; 9(1):3-13. PubMed ID: 32206594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism.
    Boulkroun S; Beuschlein F; Rossi GP; Golib-Dzib JF; Fischer E; Amar L; Mulatero P; Samson-Couterie B; Hahner S; Quinkler M; Fallo F; Letizia C; Allolio B; Ceolotto G; Cicala MV; Lang K; Lefebvre H; Lenzini L; Maniero C; Monticone S; Perrocheau M; Pilon C; Plouin PF; Rayes N; Seccia TM; Veglio F; Williams TA; Zinnamosca L; Mantero F; Benecke A; Jeunemaitre X; Reincke M; Zennaro MC
    Hypertension; 2012 Mar; 59(3):592-8. PubMed ID: 22275527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Novel Case of Somatic
    Uchida N; Amano N; Yamaoka Y; Uematsu A; Sekine Y; Suzuki M; Watanabe J; Nishimoto K; Mukai K; Fukuzawa R; Hasegawa T; Ishii T
    J Endocr Soc; 2017 Aug; 1(8):1056-1061. PubMed ID: 29264557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Machine learning approach to predict subtypes of primary aldosteronism is helpful to estimate indication of adrenal vein sampling.
    Tamaru S; Suwanai H; Abe H; Sasaki J; Ishii K; Iwasaki H; Shikuma J; Ito R; Miwa T; Sasaki T; Takamiya T; Inoue S; Saito K; Odawara M; Suzuki R
    High Blood Press Cardiovasc Prev; 2022 Jul; 29(4):375-383. PubMed ID: 35576101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presence of Subclinical Hypercortisolism in Clinical Aldosterone-Producing Adenomas Predicts Lower Clinical Success.
    Peng KY; Liao HW; Chan CK; Lin WC; Yang SY; Tsai YC; Huang KH; Lin YH; Chueh JS; Wu VC
    Hypertension; 2020 Nov; 76(5):1537-1544. PubMed ID: 32921192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KCNJ5 gene somatic mutations affect cardiac remodelling but do not preclude cure of high blood pressure and regression of left ventricular hypertrophy in primary aldosteronism.
    Rossi GP; Cesari M; Letizia C; Seccia TM; Cicala MV; Zinnamosca L; Kuppusamy M; Mareso S; Sciomer S; Iacobone M; Mantero F; Pessina AC
    J Hypertens; 2014 Jul; 32(7):1514-21; discussion 1522. PubMed ID: 24759126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathophysiological and Pharmacological Characteristics of
    Peng KY; Liao HW; Chueh JS; Pan CY; Lin YH; Chen YM; Chen PY; Huang CL; Wu VC
    Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of Somatic Mutations in Aldosterone-Producing Adenomas in Japanese Patients.
    Nanba K; Yamazaki Y; Bick N; Onodera K; Tezuka Y; Omata K; Ono Y; Blinder AR; Tomlins SA; Rainey WE; Satoh F; Sasano H
    J Clin Endocrinol Metab; 2020 Nov; 105(11):e4066-73. PubMed ID: 32844168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 18-Oxocortisol Synthesis in Aldosterone-Producing Adrenocortical Adenoma and Significance of KCNJ5 Mutation Status.
    Tezuka Y; Yamazaki Y; Kitada M; Morimoto R; Kudo M; Seiji K; Takase K; Kawasaki Y; Mitsuzuka K; Ito A; Nishikawa J; Asai N; Nakamura Y; Gomez-Sanchez CE; Ito S; Dezawa M; Sasano H; Satoh F
    Hypertension; 2019 Jun; 73(6):1283-1290. PubMed ID: 31006333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aldosterone Suppression by Dexamethasone in Patients With KCNJ5-Mutated Aldosterone-Producing Adenoma.
    Inoue K; Yamazaki Y; Kitamoto T; Hirose R; Saito J; Omura M; Sasano H; Nishikawa T
    J Clin Endocrinol Metab; 2018 Sep; 103(9):3477-3485. PubMed ID: 30020487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells.
    Monticone S; Hattangady NG; Nishimoto K; Mantero F; Rubin B; Cicala MV; Pezzani R; Auchus RJ; Ghayee HK; Shibata H; Kurihara I; Williams TA; Giri JG; Bollag RJ; Edwards MA; Isales CM; Rainey WE
    J Clin Endocrinol Metab; 2012 Aug; 97(8):E1567-72. PubMed ID: 22628608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KCNJ5 mutation is a predictor for recovery of endothelial function after adrenalectomy in patients with aldosterone-producing adenoma.
    Kishimoto S; Oki K; Maruhashi T; Kajikawa M; Mizobuchi A; Harada T; Yamaji T; Hashimoto Y; Yoshimura K; Nakano Y; Goto C; Yusoff FM; Nakashima A; Higashi Y
    Hypertens Res; 2023 Sep; 46(9):2213-2227. PubMed ID: 37463983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Meta-Analysis of Somatic KCNJ5 K(+) Channel Mutations In 1636 Patients With an Aldosterone-Producing Adenoma.
    Lenzini L; Rossitto G; Maiolino G; Letizia C; Funder JW; Rossi GP
    J Clin Endocrinol Metab; 2015 Aug; 100(8):E1089-95. PubMed ID: 26066531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different cell compositions and a novel somatic
    Zhao L; Wan J; Wang Y; Yang W; Liang Q; Wang J; Jin P
    Front Endocrinol (Lausanne); 2023; 14():1068335. PubMed ID: 36960396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutated KCNJ5 activates the acute and chronic regulatory steps in aldosterone production.
    Hattangady NG; Karashima S; Yuan L; Ponce-Balbuena D; Jalife J; Gomez-Sanchez CE; Auchus RJ; Rainey WE; Else T
    J Mol Endocrinol; 2016 Jul; 57(1):1-11. PubMed ID: 27099398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatic mutations in the KCNJ5 gene raise the lateralization index: implications for the diagnosis of primary aldosteronism by adrenal vein sampling.
    Seccia TM; Mantero F; Letizia C; Kuppusamy M; Caroccia B; Barisa M; Cicala MV; Miotto D; Rossi GP
    J Clin Endocrinol Metab; 2012 Dec; 97(12):E2307-13. PubMed ID: 23012392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance.
    Cheng CJ; Sung CC; Wu ST; Lin YC; Sytwu HK; Huang CL; Lin SH
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E155-63. PubMed ID: 25347571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.